ACCU-ID
DEAD

Serial Number

77675920

Owner

The Binding Site, Ltd.

Attorney

Jay H. Geller

Filing Date

Feb 23, 2009

Add to watchlist:

No watchlists yet
View on USPTO

ACCU-ID Trademark

Serial Number: 77675920

ACCU-ID is a trademark filed by The Binding Site, Ltd. on February 23, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

The Binding Site, Ltd. (9 trademarks)

PO Box 11712
Birmingham B144ZB , GB

Entity Type: 03

Trademark Details

Filing Date

February 23, 2009

Registration Date

Not Registered

Published for Opposition

October 6, 2009

Goods & Services

Calibrating solutions, diluents, control samples, reagents, antibodies, antigen substrates, conjugates, stopping solutions, immunofluorescence reagents, histology reagents, enzyme immunoassay reagents and general purpose reagents for medical and veterinary diagnostic use; and diagnostic and immunological test kits consisting of reagents, controls, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles, all for use in measuring the concentration of proteins, antibodies, antigens and other substances in blood, other body fluids and body tissues, or extracts thereof, for use in the diagnosis, treatment, cure, prevention or mitigation of diseases and other conditions in humans and animals; Clinical medical reagents; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; medical diagnostic kits for use in electrophoresis, immunology and serology, consisting primarily of extracts from blood or body fluids; control solutions indicative of a positive result for medical use, namely, saline solution for medical purposes; buffer solutions for diluting samples and/or reagents for medical use; reagents and blood reagents for medical and medical diagnostic purposes; electrophoretic gels for medical purposes; protein stain, for visualizing results, for medical purposes; antisera for precipitating specific proteins, for medical purposes; fixative for precipitating proteins, for medical purposes; templates for controlling the application of samples and/or antisera, for medical purposes; blotting paper and blotting tissues for removing excess liquid for gels, for medical purposes

Diagnostic kits comprised of diagnostic reagents for laboratory use, calibrators, reagent plates, buffered solutions, diluent solutions, and serum; Reagents, diagnostic reagents, biological reagents, histology reagents, enzyme radio immunoassay reagents, immunoassay reagents, antigen substrates, and antibodies for scientific research use; and test kits comprised of reagents, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles for scientific and research use using blood, body fluids, body tissues or extracts thereof; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic preparations used in science; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Reagents for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; electrophoresis gels other than for medical or veterinary purposes; calibrating solutions, diluents, reagents, antibodies, antigen substrates, conjugates, stopping solutions, immunofluorescence reagents, histology reagents, enzyme immunoassay reagents and general purpose reagents for diagnostic clinical laboratory use; Diagnostic preparations for clinical or medical laboratory use

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 2, 2010 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 2, 2010 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Dec 29, 2009 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2009 NPUB
PUBLISHED FOR OPPOSITION
Oct 6, 2009 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 1, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 1, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 27, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 27, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2009 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2009 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2009 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 4, 2009 ZZZX
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 28, 2009 TCCA
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 13, 2009 PBCR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jul 8, 2009 ASCK
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 29, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 24, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 24, 2009 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 24, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 24, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 24, 2009 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2009 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jun 15, 2009 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 31, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 18, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 18, 2009 CNSA
EXAMINER'S AMENDMENT ENTERED
May 16, 2009 XAEC
ASSIGNED TO LIE
May 15, 2009 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 15, 2009 GNEN
EXAMINERS AMENDMENT E-MAILED
May 15, 2009 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 15, 2009 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 15, 2009 GNRN
NON-FINAL ACTION E-MAILED
May 15, 2009 GNRT
NON-FINAL ACTION WRITTEN
May 15, 2009 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 12, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 12, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 11, 2009 GNRN
NON-FINAL ACTION E-MAILED
May 11, 2009 GNRT
NON-FINAL ACTION WRITTEN
May 11, 2009 CNRT
ASSIGNED TO EXAMINER
May 6, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2009 NWOS
NEW APPLICATION ENTERED
Feb 26, 2009 NWAP